concept
🤖 AI-Generated

AND

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AND: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11119Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
2Experiments
0Debates

No summary available yet.

🤖 AI-Generated

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAND
Key Genes/Proteins3R-TAU, 4R-TAU, 5-HT1AR, 6-OHDA, A2M, AADC

Wiki Pages (3)

Knowledge base pages for this entity

Canonical Page

AND

gene · 508 words

HIV-Associated Neurocognitive Disorders (HAND)

disease · 1659 words

AND

gene · 747 words

Pathway Diagram

graph TD
    subgraph Interactions["Interactions"]
        AND["AND"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
        AND["AND"] -->|"participates in"| apoptosis_pathway["apoptosis pathway"]
        AND["AND"] -->|"interacts with"| Alzheimer_s_disease["Alzheimer's disease"]
        AND["AND"] -->|"participates in"| ubiquitin_proteasome["ubiquitin-proteasome"]
        TP53["TP53"] -->|"interacts with"| AND["AND"]
        APOPTOSIS_2["APOPTOSIS"] -->|"interacts with"| AND["AND"]
    end
    subgraph Therapeutic["Therapeutic"]
        AND["AND"] -->|"expressed in"| endothelial_cells["endothelial cells"]
    end
    subgraph Pathology["Pathology"]
        AND["AND"] -->|"associated with"| Alzheimer_s_disease_1["Alzheimer's disease"]
        AND["AND"] -->|"associated with"| neurodegeneration["neurodegeneration"]
        AND["AND"] -->|"associated with"| PS1["PS1"]
        AND["AND"] -->|"associated with"| Atherosclerosis["Atherosclerosis"]
        MYC["MYC"] -->|"associated with"| AND["AND"]
        JUN["JUN"] -->|"associated with"| AND["AND"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| AND["AND"]
    end
    subgraph Signaling["Signaling"]
        CYTOKINES["CYTOKINES"] -->|"activates"| AND["AND"]
    end
    style AND fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style oxidative_stress_response fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style apoptosis_pathway fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style endothelial_cells fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer_s_disease fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer_s_disease_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PS1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ubiquitin_proteasome fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Atherosclerosis fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TP53 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MYC fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (5854)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:ANDdata_indataset_row0.00
genes-andhas_wikiwiki_page1.00
wp-3a5eaa1ed68dhas_wikiwiki_page1.00
oxidative stress responseparticipates_inpathway0.90
anddescribesgene0.90

Incoming (5265)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:ANDdata_indataset_row0.00
genes-anddescribed_bywiki_page1.00
wp-3a5eaa1ed68ddescribed_bywiki_page1.00
anddescribeswiki0.90
h-7d4a24d3targetshypothesis0.80

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
SCFA Deficiency Disrupts Microglial Homeostasis and Promotes 5.500 neurodegeneration Gut-Brain Axis in Parkinson's Disease: M
Closed-loop optogenetic targeting PV interneurons to restore 0.944 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting CA1 PV interneurons 0.927 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.922 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.900 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t 0.896 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to enhance 0.867 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II PV interneuro 0.863 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.857 Alzheimer's disease Circuit-level neural dynamics in neurode
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph 0.848 neurodegeneration What is the therapeutic window between i
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio 0.838 neurodegeneration View
Closed-loop tACS targeting EC-II parvalbumin interneurons to 0.831 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna 0.820 Alzheimer's disease Circuit-level neural dynamics in neurode
SLC7A11 System Activation Restores Cystine Uptake and GSH Sy 0.812 neurodegeneration View
Targeting the Mechanistic Link Between AQP4 Dysfunction and 0.803 neurodegeneration View
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
Excitatory Neuron Synaptic Dysfunction and Mitochondrial Str 0.790 neurodegeneration Cell type vulnerability debate in Alzhei
Closed-loop tACS targeting entorhinal cortex layer II SST in 0.784 Alzheimer's disease Circuit-level neural dynamics in neurode
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic 0.780 neurodegeneration What is the therapeutic window between t
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop 0.779 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub 0.776 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul 0.770 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC 0.760 neuroscience APOE4-driven lipid metabolism dysregulat
Iron-driven lipid peroxidation and GPX4 failure create a fer 0.750 neurodegeneration What mechanisms drive the self-amplifyin
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid 0.741 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
NRF2 failure lowers antioxidant reserve and permits recurren 0.740 neurodegeneration What mechanisms drive the self-amplifyin
VPS35 retromer activation prevents endosomal tau templating 0.740 neurodegeneration Which tau propagation mechanism predomin
Mutant-dependent amplification is context-dependent and stro 0.740 neurodegeneration Do pathogenic LRRK2 mutations amplify vo

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
MAPK pathway inhibition by QTJD through butyrate mechanism exploratory Mycoplasma pneumoniae pneumoni 0.900 0.00 Mouse macrophages proposed N/A

Related Papers (6)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and [PMID:38377788] Kalyanaraman B, Cheng G, Hardy M Redox biology 2024 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] ["Oakley, Holly", "Cole, Sarah L", "Loga The Journal of neuroscience : 2006 0
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773] ["Hardy, John", "Selkoe, Dennis J"] Science (New York, N.Y.) 2002 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning AND in their description or question text

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and r

Score: 0.896 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant

Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibiti

Score: 0.867 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-

Score: 0.863 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling a

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and bl

Score: 0.857 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 P

Score: 0.848 · neurodegeneration · 2026-04-13

## Mechanistic Overview p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-M

Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Pre

Score: 0.838 · neurodegeneration · 2026-04-17

## Mechanistic Overview Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the Self-A

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhyth

Score: 0.831 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and bl

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.827 · Alzheimer's disease · 2026-04-16

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph

Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation

Score: 0.820 · Alzheimer's disease · 2026-04-02

## Mechanistic Overview Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation starts from the cl

SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent N

Score: 0.812 · neurodegeneration · 2026-04-17

## Mechanistic Overview SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent Neuronal and Endo

Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents

Score: 0.803 · neurodegeneration · 2026-04-17

## Mechanistic Overview Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents Both Cytotoxic

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with r

Score: 0.797 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma f

NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic

Score: 0.790 · neurodegeneration · 2026-04-22

## Mechanistic Overview NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival

Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau)

Score: 0.790 · neurodegeneration · 2026-04-22

## Mechanistic Overview Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau) starts from the c

Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activa

Score: 0.784 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophag